Chimeric single-chain variable fragment-human immunoglobulin G crystallizable fragment antibody against GD2 for neuroblastoma targeted immunotherapy.

Explor Target Antitumor Ther · 2023 · PMC10776594 · PMID 38213540

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

At lower E:T ratios (1:1 and 5:1), an increasing trend of ADCP could be observed but it was not statistically significant.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.